Product Information
NARCAN 4 MG NASAL SPRAY is a brand product labeled by Emergent Devices Inc., priced at $16.4490 per EA under NDC 69547062702. Its NADAC has been published 150 times since Nov 22, 2023.
FDA first approved this application on Nov 18, 2015.
Strength
4 mg/.1mL
Manufacturer
Emergent Devices Inc.NDC
69547062702
Classification
Brand
Dosage Form
SPRAY
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
NALOXONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA208411FDA Approved
11/18/2015
On Market Since
8/28/2023
Pharmacological Classes
Price Statistics
The NADAC for NARCAN 4 MG NASAL SPRAY has been published 150 times since Nov 22, 2023, and over the history we have for it it has declined 19.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.4490 per EA |
|---|---|
| All-time high | $20.9573 (Jan 15, 2025) |
| All-time low | $16.4490 (Sep 23, 2026) |
| 52-week high | $20.5549 |
| 52-week low | $16.4490 |
| Median price | $20.5273 |
| Average price | $19.8732 |
| Largest weekly change | -3.5% (Nov 19, 2025) |
| Weeks tracked | 150 |
| Tracking since | Nov 22, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the naloxone hydrochloride nasal market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Emergent Devices Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
naloxone hydrochloride nasal market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NARCAN 4 MG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for NARCAN 4 MG NASAL SPRAY, manufactured by Emergent Devices Inc., is $16.4490 per EA (NDC 69547062702), effective Sep 30, 2026.
How has the price of NARCAN 4 MG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for NARCAN 4 MG NASAL SPRAY has declined 19.8%. It has been tracked across 150 weekly CMS publications since Nov 22, 2023.
What are the highest and lowest recorded NADAC prices for NARCAN 4 MG NASAL SPRAY?
Since Nov 22, 2023, the NADAC for NARCAN 4 MG NASAL SPRAY has ranged from a low of $16.4490 (Sep 23, 2026) to a high of $20.9573 (Jan 15, 2025), with a median of $20.5273 per EA.
Are there cheaper alternatives to NARCAN 4 MG NASAL SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of NARCAN 4 MG NASAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NARCAN 4 MG NASAL SPRAY?
NARCAN 4 MG NASAL SPRAY (NDC 69547062702) is labeled by Emergent Devices Inc., and CMS classifies it as a brand product.